According to GlobalData’s Pharmaceutical Intelligence Centre, as of August 20, 2024, 23 different cancer vaccines are in Phase I to Phase III clinical development in China. Most of these vaccines (60 per cent) are therapeutic cancer vaccines, and homegrown companies are developing the majority of them.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/LpskWwM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment